Pharmabiz6 分钟
Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults ...
Neurocrine Biosciences’ US FDA approved crinecerfont is available for children and adults to treat classic congenital adrenal hyperplasia: San Diego Tuesday, December 24, 2024, ...
Pharmabiz1 小时
Karnataka having FDA is a good move in the interest of public health: Dr BR Jagashetty
Karnataka having FDA is a good move in the interest of public health: Dr BR Jagashetty: Nandita Vijayasimha, Bengaluru Tuesday, December 24, 2024, 08:00 Hrs [IST] Karnataka is pro ...
Pharmabiz1 小时
DGTR intensifies anti-dumping probe on import of PNT from European Union
DGTR intensifies anti-dumping probe on import of PNT from European Union: Shardul Nautiyal, Mumbai Tuesday, December 24, 2024, 08:00 Hrs [IST] In a bid to ensure transparency and ...
Pharmabiz1 小时
NPPA mandates Serum Institute to continue manufacturing of TT injection one more year
NPPA mandates Serum Institute to continue manufacturing of TT injection one more year: Gireesh Babu, New Delhi Tuesday, December 24, 2024, 08:00 Hrs [IST] The National Pharmaceuti ...
Pharmabiz1 小时
Natural remedies & lifestyle changes can effectively manage PCOS: Smita Naram
Natural remedies & lifestyle changes can effectively manage PCOS: Smita Naram: Shardul Nautiyal, Mumbai Tuesday, December 24, 2024, 08:00 Hrs [IST] Polycystic Ovary Syndrome (PCOS ...
Pharmabiz1 小时
Telangana pharma industry seeks clarity in certain provisions of Revised Schedule M
Telangana pharma industry seeks clarity in certain provisions of Revised Schedule M: Peethaambaran Kunnathoor, Chennai Tuesday, December 24, 2024, 08:00 Hrs [IST] The Telangana ph ...
Pharmabiz18 小时
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial ...
US FDA approves Ionis Pharma’s Tryngolza to treat adults living with familial chylomicronemia syndrome as an adjunct to diet: Carlsbad, California Monday, December 23, 2024, 15: ...
Pharmabiz15 小时
PeproMene Bio receives $11 million investment from IFLI to advance BAFF-R CAR T-cell ...
Irvine, California Monday, December 23, 2024, 18:00 Hrs [IST] ...
Pharmabiz18 小时
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development ...
GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae: Our Bureau, Bengaluru Monday, December 23, 2024, 14 ...
Pharmabiz15 小时
Bhaskar Tare, director of Gloocal Communications, felicitated with Pride of Spandan Award ...
Bhaskar Tare, director of Gloocal Communications, felicitated with Pride of Spandan Award 2024 for contribution in healthcare: Our Bureau, Mumbai Monday, December 23, 2024, 17:15 ...
Pharmabiz17 小时
US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid ...
US FDA approves Mesoblast’s mesenchymal stromal cell therapy, Ryoncil for steroid-refractory aGvHD in children 2 months and older: Melbourne, Australia Monday, December 23, 2024 ...
Pharmabiz20 小时
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101
Vittoria Biotherapeutics doses first patient in phase 1 clinical trial of VIPER-101: Philadelphia Monday, December 23, 2024, 13:00 Hrs [IST] Vittoria Biotherapeutics, Inc, a clini ...